These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17942319)

  • 1. Endocannabinoids and psychopathology: the therapy inside.
    Drago F
    Pharmacol Res; 2007 Nov; 56(5):357-9. PubMed ID: 17942319
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endocannabinoids and psychiatric disorders: the road ahead].
    Mechoulam R
    Braz J Psychiatry; 2010 May; 32 Suppl 1():S5-6. PubMed ID: 20512265
    [No Abstract]   [Full Text] [Related]  

  • 3. Endocannabinoids and neurodegenerative diseases.
    Micale V; Mazzola C; Drago F
    Pharmacol Res; 2007 Nov; 56(5):382-92. PubMed ID: 17950616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid system: from biology to therapy.
    Bifulco M
    Pharmacol Res; 2009 Aug; 60(2):75-6. PubMed ID: 19447179
    [No Abstract]   [Full Text] [Related]  

  • 5. [Not Available].
    Fischer A
    Drug Res (Stuttg); 2017 Nov; 67(S 01):S9. PubMed ID: 29069674
    [No Abstract]   [Full Text] [Related]  

  • 6. Cannabinoids for the treatment of behavioral and psychological symptoms of dementia.
    Tampi RR; Young JJ; Tampi DJ
    Neurodegener Dis Manag; 2018 Aug; 8(4):211-213. PubMed ID: 30040030
    [No Abstract]   [Full Text] [Related]  

  • 7. Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction?
    Hiley CR; Ford WR
    Br J Pharmacol; 2003 Apr; 138(7):1183-4. PubMed ID: 12711614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No functional psychopharmacology without functional psychopathology.
    Van Praag HM
    Acta Psychiatr Scand; 2010 Dec; 122(6):438-9. PubMed ID: 20958273
    [No Abstract]   [Full Text] [Related]  

  • 10. List of drugs in development for neurodegenerative diseases: update June 2010.
    Pogačić Kramp V; Herrling P
    Neurodegener Dis; 2011; 8(1-2):44-94. PubMed ID: 20689264
    [No Abstract]   [Full Text] [Related]  

  • 11. [Documentation of psychopathological data in psychopharmacotherapy].
    Kühne GE; Grünes JU
    Agressologie; 1980; 21(A):1-5. PubMed ID: 7246871
    [No Abstract]   [Full Text] [Related]  

  • 12. [Psychiatric nosology and indication of psychopharmaceuticals].
    Vinar O
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():114-8. PubMed ID: 829608
    [No Abstract]   [Full Text] [Related]  

  • 13. Endocannabinoids rein in pain outside the brain.
    Lovinger DM
    Nat Neurosci; 2010 Oct; 13(10):1155-6. PubMed ID: 20877276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of the endocannabinoid system in endocrine regulation and energy balance.
    Pagotto U; Marsicano G; Cota D; Lutz B; Pasquali R
    Endocr Rev; 2006 Feb; 27(1):73-100. PubMed ID: 16306385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reader's response to "Endocannabinoids--the brain's own marijuana--may be linked to the metabolic syndrome".
    Armentano P
    MedGenMed; 2006; 8(4):57. PubMed ID: 17427301
    [No Abstract]   [Full Text] [Related]  

  • 16. Inflammation and aging: can endocannabinoids help?
    Marchalant Y; Brothers HM; Wenk GL
    Biomed Pharmacother; 2008; 62(4):212-7. PubMed ID: 18400455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and neuropsychiatric consequences of endocannabinoid signaling dysfunction.
    Solowij N; Monterrubio S
    Neuropsychopharmacology; 2006 Feb; 31(2):471-2. PubMed ID: 16421518
    [No Abstract]   [Full Text] [Related]  

  • 18. [Editorial: psychotropic drugs].
    Dick P
    Ther Umsch; 1975 Aug; 32(8):477. PubMed ID: 1162635
    [No Abstract]   [Full Text] [Related]  

  • 19. [Correlations between plasmatic concentrations and clinical effects of psychotropic drugs].
    Predescu V; Costa D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1979; 24(4):265-71. PubMed ID: 394259
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recent progress on drug therapy of mental diseases].
    Ueshima K
    Seishin Shinkeigaku Zasshi; 1993; 95(9):671-81. PubMed ID: 7903465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.